M

Mabwell Shanghai Bioscience Co Ltd
SSE:688062

Watchlist Manager
Mabwell Shanghai Bioscience Co Ltd
SSE:688062
Watchlist
Price: 22.92 CNY -2.51%
Market Cap: 9.2B CNY
Have any thoughts about
Mabwell Shanghai Bioscience Co Ltd?
Write Note

Gross Margin
Mabwell Shanghai Bioscience Co Ltd

96.8%
Current
78%
Average
63.9%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
96.8%
=
Gross Profit
185.3m
/
Revenue
191.4m

Gross Margin Across Competitors

Country CN
Market Cap 9.2B CNY
Gross Margin
97%
Country FR
Market Cap 6T USD
Gross Margin
0%
Country US
Market Cap 320.1B USD
Gross Margin
67%
Country US
Market Cap 147.4B USD
Gross Margin
60%
Country US
Market Cap 119.4B USD
Gross Margin
86%
Country US
Market Cap 113.8B USD
Gross Margin
78%
Country US
Market Cap 94.1B EUR
Gross Margin
76%
Country AU
Market Cap 135.4B AUD
Gross Margin
52%
Country US
Market Cap 82.6B USD
Gross Margin
87%
Country US
Market Cap 39.3B EUR
Gross Margin
75%
Country NL
Market Cap 34.3B EUR
Gross Margin
89%
No Stocks Found

Mabwell Shanghai Bioscience Co Ltd
Glance View

Market Cap
9.2B CNY
Industry
Biotechnology

Mabwell (Shanghai) Bioscience Co., Ltd. engages in the research and development, production and sales of therapeutic biological products. The company is headquartered in Shanghai, Shanghai and currently employs 1,052 full-time employees. The company went IPO on 2022-01-18. The firm's main businesses include the establishment of new varieties of drugs and the discovery of some early projects, the organization and development of preclinical research and pharmacological effects, and the development of drugs for preclinical research. The firm is also engaged in the organization, management and development of clinical trials of research species. The firm's research on drugs covers autoimmune, tumor, metabolism, ophthalmology, infection and other disease fields. The firm conducts business in domestic and foreign markets.

Intrinsic Value
27.94 CNY
Undervaluation 18%
Intrinsic Value
Price
M

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
96.8%
=
Gross Profit
185.3m
/
Revenue
191.4m
What is the Gross Margin of Mabwell Shanghai Bioscience Co Ltd?

Based on Mabwell Shanghai Bioscience Co Ltd's most recent financial statements, the company has Gross Margin of 96.8%.